Arno Therapeutics, Inc.
ARNI
$0.0001
$0.000.00%
OTC PK
| 09/30/2016 | 06/30/2016 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -11.07% | -2.07% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -32.60% | 17.17% | |||
| Operating Income | 32.60% | -17.17% | |||
| Income Before Tax | -79.65% | 42.23% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -79.65% | 42.23% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -79.65% | 42.23% | |||
| EBIT | 32.60% | -17.17% | |||
| EBITDA | 32.62% | -17.19% | |||
| EPS Basic | -67.18% | 46.19% | |||
| Normalized Basic EPS | -67.08% | 46.15% | |||
| EPS Diluted | -67.18% | 46.19% | |||
| Normalized Diluted EPS | -67.08% | 46.15% | |||
| Average Basic Shares Outstanding | 7.56% | 7.19% | |||
| Average Diluted Shares Outstanding | 7.56% | 7.19% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||